Search for stock quotes, financial statistics and more
Leede Financial analyst Douglas Loe said in an Oct. 14 update that Cipher Pharmaceuticals (Cipher St... Read More
In a Sept. 16 note, Stifel analyst Justin Keywood reiterated a “Buy” rating and C$20.00 target o... Read More
Research Capital analyst Andre Uddin maintained a “Buy” rating and C$18.60 target for Cipher Pha... Read More
Following the company’s fourth quarter results, Leede Financial analyst Douglas Loe has upgrad... Read More
A meeting with management has increased the confidence level that Stifel analyst Justin Keywood has ... Read More
Share
Tweet
pin
Share